logo

For the Inventor, By the Inventor

Oakland, CA, United States of America

David Michael Ott

This inventor holds 19 USPTO granted patents and 9 published patent applications, primarily in Medical Treatments. Top assignees: Allium Vitalis, Inc., Banctec, Incorporated, Other. Active years: 1985-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David Michael Ott. Retrieved from https://idiyas.com/inventor/david-michael-ott

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 19 

% Patents Active = 100.0

Average Co-Inventor Count = 1.2

ph-index = 6

Forward Citations = 352(Granted Patents)


Location History:

  • Houston, TX (US) (1985)
  • Westmont, IL (US) (1994)
  • Ankeny, IA (US) (2017 - 2019)
  • Oakland, CA (US) (1997 - 2020)
  • Berkeley, CA (US) (2018 - 2021)

Company Filing History:

goldMedal7 out of 7 
 
Allium Vitalis, Inc.
 patents
silverMedal2 out of 37 
 
Banctec, Incorporated
 patents
bronzeMedal10 out of 834,601 
Other
 patents

Years Active: 1985-2021

Loading Chart...
Areas of Expertise:
Dietary Treatment
Neurodegenerative Diseases
Pain Sensitization
Organosulfur Compounds
Cystein Bioavailability
Cancer Treatment
Document Image Analysis
Motorcycle Clutch Device
Vehicle Lifting System
19 patents (USPTO):Explore Patents
1. 11026911 - Method of dietary treatment for genetic and epigenetic diseases and disorders (2021-06-08),
2. 10940129 - Method of treatment for reducing pain sensitization (2021-03-09),
3. 10758498 - Method of decreasing protein-aldehyde adducts by administering a mixed disulfide of n-acetylcysteine and propyl mercaptan, propenyl mercaptan, or allyl mercaptan (2020-09-01),
4. 10583106 - Method of treating cancer by oral administration of acetate composition comprising magnesium acetate, calcium acetate or ethylacetate (2020-03-10),
5. 10310544 - Motorcycle clutch holding device (2019-06-04),
6. 10258581 - Organosulfur compounds for the prevention and treatment of neurodegenerative diseases (2019-04-16),
7. 10118891 - Organosulfur compounds for the prevention and treatment of neurodegenerative diseases (2018-11-06),
8. 9968580 - Method of treating Rett syndrome by oral administration of acetate which is provided as composition comprising magnesium acetate, calcium acetate or ethylacetate (2018-05-15),
9. 9783258 - Motorcycle clutch holding device (2017-10-10),
10. 9562007 - Organosulfur compounds for the prevention and treatment of neurodegenerative diseases (2017-02-07),
11. 9456999 - Organosulfur compounds for the prevention and treatment of neurodegenerative diseases (2016-10-04),
12. 9226885 - Personal care and medicinal products incorporating bound organosulfur groups (2016-01-05),
13. 8222299 - Organosulfur prodrugs for the prevention and treatment of infectious diseases (2012-07-17),
14. 8217084 - Medicinal products incorporating bound organosulfur groups (2012-07-10),
15. 7678833 - Method to increase the bioavailability of cysteine (2010-03-16),

Title: David Michael Ott: Innovator in Dietary Treatment and Pain Reduction

Introduction

David Michael Ott, based in Oakland, CA, is a prominent inventor with a remarkable portfolio of 19 patents. His innovative work primarily focuses on developing novel methods for treating genetic and epigenetic diseases, as well as addressing pain sensitization. Ott's contributions to the field of health and medicine reflect a commitment to enhancing the quality of life through scientific research and development.

Latest Patents

Among Ott's latest patents are significant advancements in dietary treatments. His method for dietary treatment of genetic and epigenetic diseases offers FDA-approved compositions designed as dietary supplements and nutraceuticals. This approach targets various conditions, including Rett syndrome, trinucleotide repeat diseases such as Fragile X syndrome, memory impairment, chronic inflammation, and both pre- and post-cancerous conditions that involve resilient cancer stem cells. His treatment options emphasize prophylactic measures, initiating care before symptom onset.

Additionally, he has developed a method for reducing pain sensitization through the use of lipophilic mercaptans. This innovative treatment references the role of these compounds in decreasing the formation of protein-aldehyde adducts within nociceptive nerves, leading to a significant reduction in pain sensitivity.

Career Highlights

Throughout his career, David Michael Ott has contributed to multiple projects and initiatives that bridge the gap between scientific research and practical healthcare solutions. His extensive patent portfolio underscores his ability to translate complex biomedical concepts into actionable treatments.

Collaborations

Over the years, Ott has collaborated with a range of professionals in the industry, including notable coworkers such as Cynthia D. Ott and James P. Elwell. These partnerships have enhanced his research and contributed to the successful development of his patented methods.

Conclusion

David Michael Ott stands out as an innovator dedicated to improving health outcomes through his research in dietary treatments and pain management. With a solid foundation of patents and collaborative efforts, he continues to pave the way for advancements in medical science, making significant strides toward addressing some of the most challenging health issues today.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…